rp 73401 has been researched along with Pulmonary Disease, Chronic Obstructive in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, JL; Burgess, JK; De Pedro, M; James, P; Morgan, L; Oliver, BG; Van Ly, D | 1 |
| Bednorz, M; Ghofrani, HA; Grimminger, F; Parajuli, N; Pichl, A; Schermuly, RT; Seeger, W; Seimetz, M; Weissmann, N | 1 |
| Cortijo, J; Mata, M; Morcillo, EJ; Pallardo, F | 1 |
| Dai, YR; Xia, XD; Xu, ZJ | 1 |
| Beeh, KM; Beier, J; Buhl, R; Lerch, C; Schulz, AK | 1 |
1 review(s) available for rp 73401 and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
[Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Asthma; Benzamides; Bronchodilator Agents; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Lung Diseases; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridines | 2004 |
4 other study(ies) available for rp 73401 and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Benzamides; Bronchi; Cells, Cultured; Comorbidity; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Epithelial Cells; Female; Humans; Imiquimod; In Vitro Techniques; Male; Middle Aged; Myocytes, Smooth Muscle; Phosphodiesterase 4 Inhibitors; Picornaviridae Infections; Poly I-C; Pulmonary Disease, Chronic Obstructive; Pyridines; Rhinovirus; Toll-Like Receptor 3; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptors; Young Adult | 2013 |
Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice.
Topics: Animals; Benzamides; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Hypertension, Pulmonary; Lung; Lung Compliance; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Phosphodiesterase 4 Inhibitors; Phosphodiesterase 5 Inhibitors; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Pyridines; Smoke; Smoking; Tadalafil | 2015 |
Piclamilast inhibits the pro-apoptotic and anti-proliferative responses of A549 cells exposed to H(2)O(2) via mechanisms involving AP-1 activation.
Topics: Alveolar Epithelial Cells; Antioxidants; Apoptosis; Benzamides; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation; Humans; Hydrogen Peroxide; NF-kappa B; Oligonucleotide Array Sequence Analysis; Phosphodiesterase 4 Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-jun; Pulmonary Disease, Chronic Obstructive; Pyridines; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Transcription Factor AP-1 | 2012 |
Effects of piclamilast, a selective phosphodiesterase-4 inhibitor, on oxidative burst of sputum cells from mild asthmatics and stable COPD patients.
Topics: Adult; Asthma; Benzamides; Female; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Prednisolone; Pulmonary Disease, Chronic Obstructive; Pyridines; Respiratory Burst; Sputum; Theophylline | 2004 |